Clinical Trial Update: Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2% [Phase 2]

View source ↗

Summary

Phase 2 trial update comparing topical Col-118 gel and brimonidine ophthalmic solution for erythematous rosacea; study completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythematous Rosacea

Drugs mentioned

• Col-118
• brimonidine ophthalmic solution 0.2% (brimonidine)

Snippet

Sponsor: Galderma R&D | Conditions: Erythematous Rosacea | Phase 2 | Status: COMPLETED | Results posted: 2014-08-07